✨
AI Summary
- Cue Biopharma's Anish Suri explains novel injectable biologics for targeted T cell modulation.
- The approach aims to selectively engage and modulate T cells within the body.
- This technology seeks to transform cancer treatment paradigms.
Guests on This Episode
AS
Anish Suri
1 podcast appearance